Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
- PMID: 1279431
- DOI: 10.1038/359843a0
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Abstract
Inefficient vascular supply and the resultant reduction in tissue oxygen tension often lead to neovascularization in order to satisfy the needs of the tissue. Examples include the compensatory development of collateral blood vessels in ischaemic tissues that are otherwise quiescent for angiogenesis and angiogenesis associated with the healing of hypoxic wounds. But the presumptive hypoxia-induced angiogenic factors that mediate this feedback response have not been identified. Here we show that vascular endothelial growth factor (VEGF; also known as vascular permeability factor) probably functions as a hypoxia-inducible angiogenic factor. VEGF messenger RNA levels are dramatically increased within a few hours of exposing different cell cultures to hypoxia and return to background when normal oxygen supply is resumed. In situ analysis of tumour specimens undergoing neovascularization show that the production of VEGF is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci (presumably hypoxic regions) and the clustering of capillaries alongside VEGF-producing cells.
Similar articles
-
Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.Cancer Res. 1996 Jan 15;56(2):393-401. Cancer Res. 1996. PMID: 8542597
-
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.Nature. 1994 Feb 10;367(6463):576-9. doi: 10.1038/367576a0. Nature. 1994. PMID: 8107827
-
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.Nature. 1992 Oct 29;359(6398):845-8. doi: 10.1038/359845a0. Nature. 1992. PMID: 1279432
-
Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.Am J Pathol. 2001 Mar;158(3):789-96. doi: 10.1016/S0002-9440(10)64025-4. Am J Pathol. 2001. PMID: 11238026 Free PMC article. Review. No abstract available.
-
Molecular mechanisms of developmental and tumor angiogenesis.Brain Pathol. 1994 Jul;4(3):207-18. doi: 10.1111/j.1750-3639.1994.tb00835.x. Brain Pathol. 1994. PMID: 7524960 Review.
Cited by
-
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis.Mediators Inflamm. 2016;2016:6813016. doi: 10.1155/2016/6813016. Epub 2016 Mar 30. Mediators Inflamm. 2016. PMID: 27122657 Free PMC article. Review.
-
Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications.BMC Ophthalmol. 2016 May 26;16:65. doi: 10.1186/s12886-016-0248-7. BMC Ophthalmol. 2016. PMID: 27230388 Free PMC article.
-
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).Ocul Surf. 2012 Apr;10(2):67-83. doi: 10.1016/j.jtos.2012.01.005. Epub 2012 Jan 25. Ocul Surf. 2012. PMID: 22482468 Free PMC article. Review.
-
Enhanced Osteogenic and Vasculogenic Differentiation Potential of Human Adipose Stem Cells on Biphasic Calcium Phosphate Scaffolds in Fibrin Gels.Stem Cells Int. 2016;2016:1934270. doi: 10.1155/2016/1934270. Epub 2016 Jul 28. Stem Cells Int. 2016. PMID: 27547223 Free PMC article.
-
Engineered culture models for studies of tumor-microenvironment interactions.Annu Rev Biomed Eng. 2013;15:29-53. doi: 10.1146/annurev-bioeng-071811-150028. Epub 2013 Apr 29. Annu Rev Biomed Eng. 2013. PMID: 23642249 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical